Lu Enhao, Shao Guoliang, Ma Jingqin, He Yiwei, Gong Yuanchuan, Yan Zhiping, Sha Xianyi
Key Laboratory of Smart Drug Delivery, Department of Pharmaceutics, School of Pharmacy, Fudan University, Shanghai 201203, China.
Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou 310022, China.
Pharmaceutics. 2021 May 27;13(6):799. doi: 10.3390/pharmaceutics13060799.
This study aimed to investigate the idarubicin loading method, compatible stability with contrast agent, release profiles, and morphological properties of 50-150, 100-300, and 300-500 μm CalliSpheres. The amounts of idarubicin added, loading medium, loading condition, and drug concentration were investigated as factors influencing drug loading efficiency. The drug loading rate was negatively correlated with the amount drug added and diameter of CalliSpheres and positively correlated with the drug concentration. Compared to loading in purified water and incubation at room temperature, 5% glucose, heating, and ultrasound could accelerate drug loading. The idarubicin loading efficiency was above 95% after 10 min for all three CalliSpheres with the optimized method of adding 20 mg of idarubicin at a concentration of 2 mg/mL and incubating at room temperature. The drug leak rate was under 1% within 8 h after mixing with iopamidol. Drug release tests indicated the sustained-release performance of CalliSpheres, and the time to reach 75% of the release plateau level was 8, 26, and 51 min for 50-150, 100-300, and 300-500 μm CalliSpheres, respectively. After idarubicin loading, the diameters increased by 12%, 36%, and 38% for 50-150, 100-300, and 300-500 μm CalliSpheres, respectively, and the surface of CalliSpheres was observed to become smoother than that before drug loading. All three CalliSpheres presented satisfactory loading efficiency with the optimized method, as well as proper compatible stability and sustained release performance. Among them, 100-300 μm CalliSpheres are recommended.
本研究旨在考察伊达比星的载入方法、与造影剂的配伍稳定性、释放特性以及50 - 150μm、100 - 300μm和300 - 500μm CalliSpheres微球的形态学性质。考察了伊达比星加入量、载入介质、载入条件和药物浓度等影响药物载入效率的因素。药物载入率与加入药物量和CalliSpheres微球直径呈负相关,与药物浓度呈正相关。与在纯化水中载入并室温孵育相比,5%葡萄糖、加热和超声可加速药物载入。采用优化方法,即加入20mg浓度为2mg/mL的伊达比星并室温孵育,10分钟后,三种CalliSpheres微球的伊达比星载入效率均高于95%。与碘帕醇混合后8小时内药物泄漏率低于1%。药物释放试验表明CalliSpheres微球具有缓释性能,50 - 150μm、100 - 300μm和300 - 500μm CalliSpheres微球达到释放平台水平75%的时间分别为8分钟、26分钟和51分钟。载入伊达比星后,50 - 150μm、100 - 300μm和300 - 500μm CalliSpheres微球的直径分别增加了12%、36%和38%,且观察到CalliSpheres微球表面比载入药物前更光滑。采用优化方法时,三种CalliSpheres微球均表现出令人满意的载入效率、适当的配伍稳定性和缓释性能。其中,推荐使用100 - 300μm CalliSpheres微球。